Enjoy Free Shipping on Orders above $220
10% off on orders over $120 up to $20 Use Code: MYVAL10
Palbace 75 mg capsule is a prescription medication manufactured by Pfizer Ltd. It contains Palbociclib (75mg), a CDK4/6 inhibitor that is used as part of a targeted Cancer therapy for treating hormone receptor-positive (HR+), HER2-negative Breast Cancer that has spread to other organs.
Palbociclib works by blocking specific proteins (CDK4/6) that promote Cancer cell division, slowing the progression of the disease. It is commonly used in combination with hormone therapy, such as Letrozole or Fulvestrant, to enhance treatment effectiveness and improve patient survival rates.
Doctors prescribe Palbace 75 capsules for postmenopausal women and certain male patients with advanced Breast Cancer. It helps control tumor growth, extend progression-free survival, and enhance treatment efficacy. The treatment is taken orally and requires regular medical supervision to ensure proper dosage and effectiveness.
This medication should be taken strictly under medical guidance. Dosage adjustments may be necessary based on the patient’s response and side effects. Always consult a healthcare provider before making any changes to your treatment plan.
Palbace 75 capsule plays a crucial role in managing advanced Breast Cancer by blocking cancer cell division and slowing tumor progression. It helps in prolonging progression-free survival and improving treatment outcomes when used in combination with hormone therapy.
The key benefits of Palbace 75 are as follows:
Palbace 75 is a prescription-only medication. Always consult your doctor before starting treatment. General guidelines include:
Palbace 75 mg has various strengths and substitutes. Your doctor may adjust your dosage based on your specific condition and response to treatment.
Available strengths include:
| $918.30 / 10 capsules |
Palbace 75 is generally well-tolerated, but some patients may experience mild to moderate side effects.
Common side effects include:
Seek medical help if side effects persist or worsen.
Liver disease
Patients with liver disease should use Palbace with caution, as it may affect liver function. Dose adjustments and regular liver function tests may be required to prevent complications and ensure safe treatment.
Kidney impairment
Individuals with kidney impairment should take Palbace only under medical supervision, as the medication may need dosage modifications to avoid adverse effects. Regular kidney function monitoring is recommended for safety.
Pregnant and breastfeeding women
Palbace is not recommended during pregnancy or breastfeeding due to the potential risk to the baby. Patients should use effective contraception during treatment and consult a doctor if planning pregnancy after stopping the medication.
Avoid
Avoid alcohol, grapefruit, and activities requiring alertness, as this medication can cause dizziness, drowsiness, and reduced concentration, potentially increasing the risk of accidents.
Palbace 75 works by inhibiting CDK4/6 proteins, which control cell division. Blocking these proteins slows down Cancer cell growth, helping manage HR+, HER2-negative Breast Cancer more effectively when combined with hormone therapy. This targeted approach helps in prolonging progression-free survival.
Palbace 75 should be taken once daily for 21 days, followed by a 7-day break. Swallow the capsule whole with food at the same time each day. Regular blood tests are needed to monitor side effects and adjust dosages if necessary to ensure safe and effective treatment.
The duration of palbace treatment varies depending on the patient and the Cancer stage. Typically, it is continued as long as it remains effective and side effects are manageable. Your doctor will determine the best course based on your response to therapy and overall health condition.
No, stopping Palbace without medical guidance can lead to Cancer progression and reduce treatment effectiveness. Even if you feel better, follow your doctor’s instructions and complete the prescribed treatment cycle for optimal disease management.
If you miss a dose, skip it and take the next scheduled dose at the usual time. Do not double the Palbace dose to compensate for the missed one, as this may increase the risk of side effects and impact treatment safety.
Yes, Palbace may cause mild to moderate hair thinning in some patients. However, this side effect is usually temporary, and hair growth may resume after stopping the treatment. Proper hair care and nutrition may help reduce hair thinning.
